These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11140740)

  • 1. Structure-activity studies of 5-substituted pyridopyrimidines as adenosine kinase inhibitors.
    Cowart M; Lee CH; Gfesser GA; Bayburt EK; Bhagwat SS; Stewart AO; Yu H; Kohlhaas KL; McGaraughty S; Wismer CT; Mikusa J; Zhu C; Alexander KM; Jarvis MF; Kowaluk EA
    Bioorg Med Chem Lett; 2001 Jan; 11(1):83-6. PubMed ID: 11140740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyridopyrimidine analogues as novel adenosine kinase inhibitors.
    Zheng GZ; Lee C; Pratt JK; Perner RJ; Jiang MQ; Gomtsyan A; Matulenko MA; Mao Y; Koenig JR; Kim KH; Muchmore S; Yu H; Kohlhaas K; Alexander KM; McGaraughty S; Chu KL; Wismer CT; Mikusa J; Jarvis MF; Marsh K; Kowaluk EA; Bhagwat SS; Stewart AO
    Bioorg Med Chem Lett; 2001 Aug; 11(16):2071-4. PubMed ID: 11514141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of 6,7-disubstituted 4-aminopyrido[2,3-d]pyrimidines as adenosine kinase inhibitors.
    Perner RJ; Lee CH; Jiang M; Gu YG; Didomenico S; Bayburt EK; Alexander KM; Kohlhaas KL; Jarvis MF; Kowaluk EL; Bhagwat SS
    Bioorg Med Chem Lett; 2005 Jun; 15(11):2803-7. PubMed ID: 15911258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and structure-activity relationships of 5-heteroatom-substituted pyridopyrimidines as adenosine kinase inhibitors.
    Gfesser GA; Bayburt EK; Cowart M; DiDomenico S; Gomtsyan A; Lee CH; Stewart AO; Jarvis MF; Kowaluk EA; Bhagwat SS
    Eur J Med Chem; 2003 Mar; 38(3):245-52. PubMed ID: 12667691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine kinase inhibitors: polar 7-substitutent of pyridopyrimidine derivatives improving their locomotor selectivity.
    Zheng GZ; Mao Y; Lee CH; Pratt JK; Koenig JR; Perner RJ; Cowart MD; Gfesser GA; McGaraughty S; Chu KL; Zhu C; Yu H; Kohlhaas K; Alexander KM; Wismer CT; Mikusa J; Jarvis MF; Kowaluk EA; Stewart AO
    Bioorg Med Chem Lett; 2003 Sep; 13(18):3041-4. PubMed ID: 12941329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of pteridine and pyrazolopyrimidine based adenosine kinase inhibitors.
    Gomtsyan A; Didomenico S; Lee CH; Stewart AO; Bhagwat SS; Kowaluk EA; Jarvis MF
    Bioorg Med Chem Lett; 2004 Aug; 14(16):4165-8. PubMed ID: 15261263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and structure-activity relationship of 6-alkynylpyrimidines as potent adenosine kinase inhibitors.
    Gomtsyan A; Didomenico S; Lee CH; Matulenko MA; Kim K; Kowaluk EA; Wismer CT; Mikusa J; Yu H; Kohlhaas K; Jarvis MF; Bhagwat SS
    J Med Chem; 2002 Aug; 45(17):3639-48. PubMed ID: 12166937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonnucleoside inhibitors of adenosine kinase.
    Gomtsyan A; Lee CH
    Curr Pharm Des; 2004; 10(10):1093-103. PubMed ID: 15078144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analgesic and anti-inflammatory effects of A-286501, a novel orally active adenosine kinase inhibitor.
    Jarvis MF; Yu H; McGaraughty S; Wismer CT; Mikusa J; Zhu C; Chu K; Kohlhaas K; Cowart M; Lee CH; Stewart AO; Cox BF; Polakowski J; Kowaluk EA
    Pain; 2002 Mar; 96(1-2):107-18. PubMed ID: 11932067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the ability of adenosine kinase inhibitors and adenosine receptor agonists to attenuate thermal hyperalgesia and reduce motor performance in rats.
    Jarvis MF; Mikusa J; Chu KL; Wismer CT; Honore P; Kowaluk EA; McGaraughty S
    Pharmacol Biochem Behav; 2002 Oct; 73(3):573-81. PubMed ID: 12151032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5,6,7-trisubstituted 4-aminopyrido[2,3-d]pyrimidines as novel inhibitors of adenosine kinase.
    Perner RJ; Gu YG; Lee CH; Bayburt EK; McKie J; Alexander KM; Kohlhaas KL; Wismer CT; Mikusa J; Jarvis MF; Kowaluk EA; Bhagwat SS
    J Med Chem; 2003 Nov; 46(24):5249-57. PubMed ID: 14613327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-(3-Bromophenyl)-7-(6-morpholin-4-ylpyridin-3-yl)pyrido[2,3-d]pyrimidin-4-ylamine: structure-activity relationships of 7-substituted heteroaryl analogs as non-nucleoside adenosine kinase inhibitors.
    Matulenko MA; Lee CH; Jiang M; Frey RR; Cowart MD; Bayburt EK; Didomenico S; Gfesser GA; Gomtsyan A; Zheng GZ; McKie JA; Stewart AO; Yu H; Kohlhaas KL; Alexander KM; McGaraughty S; Wismer CT; Mikusa J; Marsh KC; Snyder RD; Diehl MS; Kowaluk EA; Jarvis MF; Bhagwat SS
    Bioorg Med Chem; 2005 Jun; 13(11):3705-20. PubMed ID: 15863000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and optimization of 2-aryl oxazolo-pyrimidines as adenosine kinase inhibitors using liquid phase parallel synthesis.
    Bauser M; Delapierre G; Hauswald M; Flessner T; D'Urso D; Hermann A; Beyreuther B; De Vry J; Spreyer P; Reissmüller E; Meier H
    Bioorg Med Chem Lett; 2004 Apr; 14(8):1997-2000. PubMed ID: 15050645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin- 3-yl)pyrido[2,3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties. II. In vivo characterization in the rat.
    Kowaluk EA; Mikusa J; Wismer CT; Zhu CZ; Schweitzer E; Lynch JJ; Lee CH; Jiang M; Bhagwat SS; Gomtsyan A; McKie J; Cox BF; Polakowski J; Reinhart G; Williams M; Jarvis MF
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1165-74. PubMed ID: 11082454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A-134974: a novel adenosine kinase inhibitor, relieves tactile allodynia via spinal sites of action in peripheral nerve injured rats.
    Zhu CZ; Mikusa J; Chu KL; Cowart M; Kowaluk EA; Jarvis MF; McGaraughty S
    Brain Res; 2001 Jun; 905(1-2):104-10. PubMed ID: 11423084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of 4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin-3-yl)pyrido[2,3-d]pyrimidine, an orally active, non-nucleoside adenosine kinase inhibitor.
    Lee CH; Jiang M; Cowart M; Gfesser G; Perner R; Kim KH; Gu YG; Williams M; Jarvis MF; Kowaluk EA; Stewart AO; Bhagwat SS
    J Med Chem; 2001 Jun; 44(13):2133-8. PubMed ID: 11405650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent developments in the discovery of novel adenosine kinase inhibitors: mechanism of action and therapeutic potential.
    McGaraughty S; Cowart M; Jarvis MF
    CNS Drug Rev; 2001; 7(4):415-32. PubMed ID: 11830758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of clitocine analogues as adenosine kinase inhibitors.
    Lee CH; Daanen JF; Jiang M; Yu H; Kohlhaas KL; Alexander K; Jarvis MF; Kowaluk EL; Bhagwat SS
    Bioorg Med Chem Lett; 2001 Sep; 11(18):2419-22. PubMed ID: 11549437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and biochemical studies on novel non-nucleoside inhibitors of the enzyme adenosine kinase.
    Park J; Vaidyanathan G; Singh B; Gupta RS
    Protein J; 2007 Apr; 26(3):203-12. PubMed ID: 17205396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholinopyridin-3-yl)pyrido[2, 3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties: I. In vitro characterization and acute antinociceptive effects in the mouse.
    Jarvis MF; Yu H; Kohlhaas K; Alexander K; Lee CH; Jiang M; Bhagwat SS; Williams M; Kowaluk EA
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1156-64. PubMed ID: 11082453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.